Evidence map›Paper›PMID 11248104›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines.

E Izzo, J Auta, F Impagnatiello, C Pesold, A Guidotti, E Costa

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. VALTOCONeurology international · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice.The international journal of neuropsychopharmacology · 2013
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Calcium/calmodulin-dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

E IzzoPsychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois, Chicago, IL 60612, USA.
J Auta
F Impagnatiello
C Pesold
A Guidotti
E Costa
University of Illinois Urbana-Champaign · USUniversity of Illinois Chicago · US

Funding

PHARMACOLOGY--ALLOSTERIC MODULATORS OF GABAA RECEPTORSR01MH049486 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GUIDOTTI, ALESSANDRO · 1992 to 2002
$694k
MOLECULAR MECHANISMS OF DIAZEPAM TOLERANCER01MH056500 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COSTA, ERMINIO · 1997 to 1999
–
NIMH NIH HHS MH 49486NIMH NIH HHS MH 56500
6 · The paper itself

Abstract

Protracted administration of diazepam elicits tolerance, whereas discontinuation of treatment results in signs of dependence. Tolerance to the anticonvulsant action of diazepam is present in an early phase (6, 24, and 36 h) but disappears in a late phase (72-96 h) of withdrawal. In contrast, signs of dependence such as decrease in open-arm entries on an elevated plus-maze and increased susceptibility to pentylenetetrazol-induced seizures were apparent 96 h (but not 12, 24, or 48 h) after diazepam withdrawal. During the first 72 h of withdrawal, tolerance is associated with changes in the expression of GABA(A) (gamma-aminobutyric acid type A) receptor subunits (decrease in gamma(2) and alpha(1); increase in alpha(5)) and with an increase of mRNA expression of the most abundant form of glutamic acid decarboxylase (GAD), GAD(67). In contrast, dl-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor GluR1 subunit mRNA and cognate protein, which are normal during the early phase of diazepam withdrawal, increase by approximately 30% in cortex and hippocampus in association with the appearance of signs of dependence 96 h after diazepam withdrawal. Immunohistochemical studies of GluR1 subunit expression with gold-immunolabeling technique reveal that the increase of GluR1 subunit protein is localized to layer V pyramidal neurons and their apical dendrites in the cortex, and to pyramidal neurons and in their dendritic fields in hippocampus. The results suggest an involvement of GABA-mediated processes in the development and maintenance of tolerance to diazepam, whereas excitatory amino acid-related processes (presumably via AMPA receptors) may be involved in the expression of signs of dependence after withdrawal.

Indexed as

AnimalsBrainDiazepamDrug ToleranceFrontal LobeGABA ModulatorsGene Expression ProfilingGlutamate DecarboxylaseHippocampusIsoenzymesMaleOccipital LobeRatsRats, Inbred F344Receptors, AMPARNA, MessengerDiazepamGABA ModulatorsGlutamate Decarboxylaseglutamate decarboxylase 1glutamate decarboxylase 2glutamate receptor ionotropic, AMPA 2glutamate receptor ionotropic, AMPA 3glutamate receptor ionotropic, AMPA 4IsoenzymesReceptors, AMPARNA, Messenger

Identifiers

PMID11248104
PMCPMC30679
OpenAlexW2068003831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.